Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists

Table 3 Sexual function by the type of ovarian function suppression in patients with breast cancer

	Ovarian function suppression
	Ovarian Ablation (OA) N=174	GnRH agonist (GnRHa) N=389	t or χ² value	P value
FSFI total scores
Mean (SD)	19.3 ± 8.5	17.8 ± 8.7		0.205
Median (IQR)	19.6(13.0-26.7)	17.8(12.2-24.3)
Range	2-34	2-34
Sexual dysfunction (FSFI<23), n(%)	107 (61.5)	281 (72.2)	6.476	0.011

FSFI Female sexual function index, SE Standard errors, IQR Interquartile range (25^th, 75^th percentiles).

ISSN: 1471-244X